Advanced search
Publication Cover
Biomarkers Volume 21, 2016 - Issue 2
Submit an article Journal homepage
1,015
Views
84
CrossRef citations to date
0
Altmetric
Original Article

A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson’s disease

Hui DongState Key Laboratory of Pharmaceutical Biotechnology, Nanjing Advanced Institute for Life Sciences, Nanjing University School of Life Sciences, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University, Nanjing, China,
,
Cheng WangState Key Laboratory of Pharmaceutical Biotechnology, Nanjing Advanced Institute for Life Sciences, Nanjing University School of Life Sciences, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University, Nanjing, China, ;Department of Clinical Laboratory, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China, and Correspondence[email protected] [email protected]
,
Sunbin LuState Key Laboratory of Pharmaceutical Biotechnology, Nanjing Advanced Institute for Life Sciences, Nanjing University School of Life Sciences, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University, Nanjing, China,
,
Cuiyu YuDepartment of Neurology, Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China
,
Lei HuangState Key Laboratory of Pharmaceutical Biotechnology, Nanjing Advanced Institute for Life Sciences, Nanjing University School of Life Sciences, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University, Nanjing, China,
,
Wuruo FengDepartment of Neurology, Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China
,
Hui XuDepartment of Neurology, Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China
,
Xi ChenState Key Laboratory of Pharmaceutical Biotechnology, Nanjing Advanced Institute for Life Sciences, Nanjing University School of Life Sciences, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University, Nanjing, China,
,
Ke ZenState Key Laboratory of Pharmaceutical Biotechnology, Nanjing Advanced Institute for Life Sciences, Nanjing University School of Life Sciences, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University, Nanjing, China,
,
Qiao YanState Key Laboratory of Pharmaceutical Biotechnology, Nanjing Advanced Institute for Life Sciences, Nanjing University School of Life Sciences, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University, Nanjing, China, Correspondence[email protected] [email protected]
,
Weiguo LiuDepartment of Neurology, Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaCorrespondence[email protected]
,
Chunni ZhangState Key Laboratory of Pharmaceutical Biotechnology, Nanjing Advanced Institute for Life Sciences, Nanjing University School of Life Sciences, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University, Nanjing, China, ;Department of Clinical Laboratory, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China, and Correspondence[email protected] [email protected]
&
Chen-Yu ZhangState Key Laboratory of Pharmaceutical Biotechnology, Nanjing Advanced Institute for Life Sciences, Nanjing University School of Life Sciences, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University, Nanjing, China, Correspondence[email protected] [email protected]
 show all
Pages 129-137 | Received 16 Apr 2015, Accepted 01 Nov 2015, Published online: 03 Dec 2015

Citations (84)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Betul Ozdilek & Berna Demircan. (2021) Serum microRNA expression levels in Turkish patients with Parkinson’s disease. International Journal of Neuroscience 131:12, pages 1181-1189.
Read now

Articles from other publishers (83)

Osama A. Mohammed, Mohammed S. Elballal, Ahmed A. El-Husseiny, Emad Gamil Khidr, Manar Mohammed El Tabaa, Ola Elazazy, Mai A. Abd-Elmawla, Ahmed E. Elesawy, Henwa M. Ibrahim, Ahmed I. Abulsoud, Walaa A. El-Dakroury, Sherif S. Abdel Mageed, Mahmoud A. Elrebehy, Yousra Nomier, Mustafa Ahmed Abdel-Reheim, Hussein M. El-Husseiny, Abdulla M.A. Mahmoud, Sameh Saber & Ahmed S. Doghish. (2024) Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson’s disease. Pathology - Research and Practice 253, pages 155023.
Crossref
Arpana Parihar, Nishant Kumar Choudhary & Raju Khan. 2024. Smart Diagnostics for Neurodegenerative Disorders. Smart Diagnostics for Neurodegenerative Disorders 279 310 .
Diane Guévremont, Joyeeta Roy, Nicholas J. Cutfield & Joanna M. Williams. (2023) MicroRNAs in Parkinson’s disease: a systematic review and diagnostic accuracy meta-analysis. Scientific Reports 13:1.
Crossref
Xiangqing Hou & Garry Wong. (2023) Nomogram for Early Prediction of Parkinson’s Disease Based on microRNA Profiles and Clinical Variables. Journal of Parkinson's Disease 13:4, pages 473-484.
Crossref
Adam Szelągowski & Mariusz Kozakiewicz. (2023) A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson’s Disease. Oxidative Medicine and Cellular Longevity 2023, pages 1-18.
Crossref
Kamatham Pushpa Tryphena, Gurpreet Singh, Naitik Jain, Paras Famta, Saurabh Srivastava, Shashi Bala Singh & Dharmendra Kumar Khatri. (2023) Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics. Mechanisms of Ageing and Development 211, pages 111800.
Crossref
Saima Owais & Yasir Hasan Siddique. (2023) A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches. CNS & Neurological Disorders - Drug Targets 22:3, pages 353-380.
Crossref
Hui Ma, Pingzhuang Ge, Shixiong Bian, Yunlei Li, Aixin Ni, Ran Zhang, Yuanmei Wang, Jinmeng Zhao, Yunhe Zong, Jingwei Yuan, Yanyan Sun & Jilan Chen. (2023) miR-193-5p negatively regulates PIK3CD to promote crop fibrocyte proliferation in pigeon (Columba livia). Poultry Science 102:2, pages 102378.
Crossref
Amrita Kulkarni, Kumari Preeti, Kamatham Pushpa Tryphena, Saurabh Srivastava, Shashi Bala Singh & Dharmendra Kumar Khatri. (2023) Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics. Ageing Research Reviews 84, pages 101816.
Crossref
Ajay Elangovan, Dhivya Venkatesan, Priyanka Selvaraj, Md. Younus Pasha, Harysh Winster Suresh Babu, Mahalaxmi Iyer, Arul Narayanasamy, Mohana Devi Subramaniam, Abilash Valsala Gopalakrishnan, Nachimuthu Senthil Kumar & Balachandar Vellingiri. (2022) miRNA in Parkinson's disease: From pathogenesis to theranostic approaches. Journal of Cellular Physiology 238:2, pages 329-354.
Crossref
Wei Yao, Ping Zhou, Qiujin Yan, Xiulin Wu, Yaru Xia, Wenshi Li, Xuhang Li & Fan Zhu. (2023) ERVWE1 Reduces Hippocampal Neuron Density and Impairs Dendritic Spine Morphology through Inhibiting Wnt/JNK Non-Canonical Pathway via miR-141-3p in Schizophrenia. Viruses 15:1, pages 168.
Crossref
Anastasia Bougea & Leonidas Stefanis. 2023.
Natalia S. Ardashirova, Natalia Yu. Abramycheva, Ekaterina Yu. Fedotova & Sergey N. Illarioshkin. (2022) MicroRNA Expression Profile Changes in the Leukocytes of Parkinson’s Disease Patients. Acta Naturae 14:3, pages 79-84.
Crossref
Steven G. Fagan & Shona Pfeiffer. 2022. COVID-19, Neuroimmunology and Neural Function. COVID-19, Neuroimmunology and Neural Function.
Ayaz M. Belkozhayev, Minnatallah Al-Yozbaki, Alex George, Raigul Ye Niyazova, Kamalidin O. Sharipov, Lee J. Byrne & Cornelia M. Wilson. (2022) Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration. Current Neuropharmacology 20:8, pages 1450-1478.
Crossref
Ocana Noronha, Lucia Mesarosovo, Jasper J. Anink, Anand Iyer, Eleonora Aronica & James D. Mills. (2022) Differentially Expressed miRNAs in Age-Related Neurodegenerative Diseases: A Meta-Analysis. Genes 13:6, pages 1034.
Crossref
W.T. Zhang, Y.J. Wang, Y.F. Yao, G.X. Zhang, Y.N. Zhang & S.S. Gao. (2022) Circulating microRNAs as potential biomarkers for the diagnosis of Parkinson's disease: A meta-analysis. Neurología.
Crossref
Amr Ghit & Hany El Deeb. (2022) Cytokines, miRNAs, and Antioxidants as Combined Non-invasive Biomarkers for Parkinson’s Disease. Journal of Molecular Neuroscience 72:5, pages 1133-1140.
Crossref
Amy Xu, Valentina L. Kouznetsova & Igor F. Tsigelny. (2022) Alzheimer’s Disease Diagnostics Using miRNA Biomarkers and Machine Learning. Journal of Alzheimer's Disease 86:2, pages 841-859.
Crossref
Ming-Che Kuo, Sam Chi-Hao Liu, Ya-Fang Hsu & Ruey-Meei Wu. (2021) The role of noncoding RNAs in Parkinson’s disease: biomarkers and associations with pathogenic pathways. Journal of Biomedical Science 28:1.
Crossref
Ida Manna, Andrea Quattrone, Selene De Benedittis, Basilio Vescio, Enrico Iaccino & Aldo Quattrone. (2021) Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study. Parkinsonism & Related Disorders 93, pages 77-84.
Crossref
Qijie Li, Lu Fang, Junjie Chen, Siqi Zhou, Kai Zhou, Fengrui Cheng, Ying Cen, Yong Qing & Junliang Wu. (2021) Exosomal MicroRNA-21 Promotes Keloid Fibroblast Proliferation and Collagen Production by Inhibiting Smad7. Journal of Burn Care & Research 42:6, pages 1266-1274.
Crossref
Lanting Li, Jingru Ren, Chenxi Pan, Yuqian Li, Jianxia Xu, Hui Dong, Yong Chen & Weiguo Liu. (2021) Serum miR-214 Serves as a Biomarker for Prodromal Parkinson’s Disease. Frontiers in Aging Neuroscience 13.
Crossref
Dawit Tesfaye, Nico Menjivar & Samuel Gebremedhn. (2021) Current knowledge and the future potential of extracellular vesicles in mammalian reproduction. Reproduction, Fertility and Development 34:2, pages 174-189.
Crossref
Aimee Rodica Chis, Alexandra Ioana Moatar, Cristina Dijmarescu, Cecilia Rosca, Ruxandra Julia Vorovenci, Inge Krabbendam, Amalia Dolga, Cristina Bejinar, Catalin Marian, Ioan Ovidiu Sirbu & Mihaela Simu. (2021) Plasma hsa‐mir‐19b is a potential LevoDopa therapy marker. Journal of Cellular and Molecular Medicine 25:18, pages 8715-8724.
Crossref
Navneet Ammal KaideryManuj AhujaSudarshana M SharmaBobby Thomas. (2021) An Emerging Role of miRNAs in Neurodegenerative Diseases: Mechanisms and Perspectives on miR146a . Antioxidants & Redox Signaling 35:7, pages 580-594.
Crossref
Meng Cai, Songshan Chai, Tao Xiong, Jun Wei, Weibing Mao, Yasha Zhu, Xiang Li, Wei Wei, Xuan Dai, Bangkun Yang, Wen Liu, Bing Shu, Mengyang Wang, Taojunjin Lu, Yuankun Cai, Zhixin Zheng, Zhimin Mei, Yixuan Zhou, Jingyi Yang, Jingwei Zhao, Lei Shen, Joshua Wing Kei Ho, Jincao Chen & Nanxiang Xiong. (2021) Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson’s Disease. Frontiers in Cell and Developmental Biology 9.
Crossref
Ángela García-Fonseca, Cynthia Martin-Jimenez, George E. Barreto, Andres Felipe Aristizábal Pachón & Janneth González. (2021) The Emerging Role of Long Non-Coding RNAs and MicroRNAs in Neurodegenerative Diseases: A Perspective of Machine Learning. Biomolecules 11:8, pages 1132.
Crossref
Aimee Rodica Chiș, Alexandra Ioana Moatăr & Ioan-Ovidiu Sîrbu. (2021) A Disease in Search for a Biomarker: MicroRNAs in Parkinson’s Disease. Timisoara Medical Journal 2021:1, pages 1.
Crossref
Yudong Wu, Qian Li, Renshuai Zhang, Xiaoli Dai, Wujun Chen & Dongming Xing. (2021) Circulating microRNAs: Biomarkers of disease. Clinica Chimica Acta 516, pages 46-54.
Crossref
Yong Hui Nies, Nor Haliza Mohamad Najib, Wei Ling Lim, Mohd Amir Kamaruzzaman, Mohamad Fairuz Yahaya & Seong Lin Teoh. (2021) MicroRNA Dysregulation in Parkinson’s Disease: A Narrative Review. Frontiers in Neuroscience 15.
Crossref
Yimin Yang, Yanhua Li, Hongmei Yang, Jianxing Guo & Nan Li. (2021) Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease. Frontiers in Molecular Neuroscience 14.
Crossref
Qingxuan Lai, Nikolai Kovzel, Ruslan Konovalov & Ilya A. Vinnikov. 2021. Autophagy: Biology and Diseases. Autophagy: Biology and Diseases 191 264 .
Agnieszka Zmyslowska, Marcin Stanczak, Zuzanna Nowicka, Arleta Waszczykowska, Dobromila Baranska, Wojciech Fendler, Maciej Borowiec & Wojciech Młynarski. (2020) Serum microRNA as indicators of Wolfram syndrome’s progression in neuroimaging studies. BMJ Open Diabetes Research & Care 8:2, pages e001379.
Crossref
Shufang Zhou, Dan Zhang, Junnan Guo, Junshi Zhang & Yong Chen. (2020) Knockdown of SNHG14 Alleviates MPP+-Induced Injury in the Cell Model of Parkinson’s Disease by Targeting the miR-214-3p/KLF4 Axis. Frontiers in Neuroscience 14.
Crossref
Shubhra Acharya, Antonio Salgado-Somoza, Francesca Maria Stefanizzi, Andrew I. Lumley, Lu Zhang, Enrico Glaab, Patrick May & Yvan Devaux. (2020) Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease. International Journal of Molecular Sciences 21:18, pages 6513.
Crossref
Marco Ragusa, Maria Santagati, Federica Mirabella, Giovanni Lauretta, Matilde Cirnigliaro, Duilia Brex, Cristina Barbagallo, Carla Noemi Domini, Mariangela Gulisano, Rita Barone, Laura Trovato, Salvatore Oliveri, Gino Mongelli, Ambra Spitale, Davide Barbagallo, Cinzia Di Pietro, Stefania Stefani, Renata Rizzo & Michele Purrello. (2020) Potential Associations Among Alteration of Salivary miRNAs, Saliva Microbiome Structure, and Cognitive Impairments in Autistic Children. International Journal of Molecular Sciences 21:17, pages 6203.
Crossref
Yanmei Chen, Jingxue Zheng, Lufen Su, Fengxian Chen, Ruihan Zhu, Xiaochun Chen & Qinyong Ye. (2020) Increased Salivary microRNAs That Regulate DJ-1 Gene Expression as Potential Markers for Parkinson’s Disease. Frontiers in Aging Neuroscience 12.
Crossref
N. S. Ardashirova, E. Yu. Fedotova & S. N. Illarioshkin. (2020) The Role of MicroRNA in the Pathogenesis and Diagnostics of Parkinson’s Disease. Neurochemical Journal 14:2, pages 127-132.
Crossref
Haiting Li, Ling Yu, Min Li, Xiaohui Chen, Qun Tian, Yanyan Jiang & Nan Li. (2020) MicroRNA‐150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease. Molecular Genetics & Genomic Medicine 8:4.
Crossref
Epaminondas Doxakis. (2020) Cell-free microRNAs in Parkinson’s disease: potential biomarkers that provide new insights into disease pathogenesis. Ageing Research Reviews 58, pages 101023.
Crossref
Stylianos Ravanidis, Anastasia Bougea, Nikolaos Papagiannakis, Matina Maniati, Christos Koros, Athina‐Maria Simitsi, Maria Bozi, Ioanna Pachi, Maria Stamelou, George P. Paraskevas, Elisabeth Kapaki, Marina Moraitou, Helen Michelakakis, Leonidas Stefanis & Epaminondas Doxakis. (2019) Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's Disease. Movement Disorders 35:3, pages 457-467.
Crossref
M.M.J. van den Berg, J. Krauskopf, J.G. Ramaekers, J.C.S. Kleinjans, J. Prickaerts & J.J. Briedé. (2020) Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Progress in Neurobiology 185, pages 101732.
Crossref
Mario J. Bertogliat, Kahlilia C. Morris-Blanco & Raghu Vemuganti. (2020) Epigenetic mechanisms of neurodegenerative diseases and acute brain injury. Neurochemistry International 133, pages 104642.
Crossref
Fengjun Cao, Zhongjie Liu & Guanjun Sun. (2020) Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-β induced neurotoxicity by targeting PTEN. Experimental Gerontology 130, pages 110814.
Crossref
Chi-Hsiu Liu, Shuo Huang, William R. Britton & Jing Chen. (2020) MicroRNAs in Vascular Eye Diseases. International Journal of Molecular Sciences 21:2, pages 649.
Crossref
Liang Li & Jin Wang. (2019) Roles of extracellular microRNAs in central nervous system. ExRNA 1:1.
Crossref
Gen Li, Jianfang Ma, Shishuang Cui, Yixi He, Qin Xiao, Jun Liu & Shengdi Chen. (2019) Parkinson’s disease in China: a forty-year growing track of bedside work. Translational Neurodegeneration 8:1.
Crossref
Suh Yee Goh, Yin Xia Chao, Shaikali Thameem Dheen, Eng-King Tan & Samuel Sam-Wah Tay. (2019) Role of MicroRNAs in Parkinson’s Disease. International Journal of Molecular Sciences 20:22, pages 5649.
Crossref
Jie Fu, Lilei Peng, Tao Tao, Yangmei Chen, Zuoxiao Li & Jinglun Li. (2019) Regulatory roles of the miR-200 family in neurodegenerative diseases. Biomedicine & Pharmacotherapy 119, pages 109409.
Crossref
Marcelo A. Mori, Raissa G. Ludwig, Ruben Garcia-Martin, Bruna B. Brandão & C. Ronald Kahn. (2019) Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease. Cell Metabolism 30:4, pages 656-673.
Crossref
Monireh Khordadmehr, Roya Shahbazi, Sanam Sadreddini & Behzad Baradaran. (2019) miR‐193: A new weapon against cancer. Journal of Cellular Physiology 234:10, pages 16861-16872.
Crossref
Sacha Bohler, Julian Krauskopf, Almudena Espín-Pérez, Stephan Gebel, Domenico Palli, Panu Rantakokko, Hannu Kiviranta, Soterios A. Kyrtopoulos, Rudi Balling & Jos Kleinjans. (2019) Genes associated with Parkinson's disease respond to increasing polychlorinated biphenyl levels in the blood of healthy females. Environmental Pollution 250, pages 107-117.
Crossref
Jessica Schulz, Petros Takousis, Inken Wohlers, Ivie O.G. Itua, Valerija Dobricic, Gerta Rücker, Harald Binder, Lefkos Middleton, John P.A. Ioannidis, Robert Perneczky, Lars Bertram & Christina M. Lill. (2019) Meta‐analyses identify differentially expressed microRNAs in Parkinson's disease. Annals of Neurology 85:6, pages 835-851.
Crossref
Callum N. Watson, Antonio Belli & Valentina Di Pietro. (2019) Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease. Frontiers in Genetics 10.
Crossref
Zhaofei Yang, Tianbai Li, Yanhua Cui, Song Li, Cheng Cheng, Bairong Shen & Weidong Le. (2019) Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson’s Disease: A Potential Disease Biomarker. Frontiers in Neuroscience 13.
Crossref
Thein Than Htike, Sachin Mishra, Sundramurthy Kumar, Parasuraman Padmanabhan & Balázs Gulyás. (2018) Peripheral Biomarkers for Early Detection of Alzheimer’s and Parkinson’s Diseases. Molecular Neurobiology 56:3, pages 2256-2277.
Crossref
Ana Gámez-Valero, Katrin Beyer & Francesc E. Borràs. (2019) Extracellular vesicles, new actors in the search for biomarkers of dementias. Neurobiology of Aging 74, pages 15-20.
Crossref
Huaping Huang, Tangying Li, Mingjing Chen, Feng Liu, Haifeng Wu, Jie Wang, Jialiang Chen & Xi Li. (2018) Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells. Cellular & Molecular Biology Letters 23:1.
Crossref
Hector Rosas-Hernandez, Srinivasulu Chigurupati, James Raymick, Bonnie Robinson, Elvis Cuevas, Joseph Hanig & Sumit Sarkar. (2018) Identification of altered microRNAs in serum of a mouse model of Parkinson’s disease. Neuroscience Letters 687, pages 1-9.
Crossref
Palaniswamy Ramaswamy, Rita Christopher, Pramod Kumar Pal & Ravi Yadav. (2018) MicroRNAs to differentiate Parkinsonian disorders: Advances in biomarkers and therapeutics. Journal of the Neurological Sciences 394, pages 26-37.
Crossref
Xiaojuan Ren, Hui Zhang, Hui Cong, Xudong Wang, Hongbing Ni, Xianjuan Shen & Shaoqing Ju. (2018) Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer. Pathology & Oncology Research 24:4, pages 739-744.
Crossref
Anna Elisa Roser, Lucas Caldi Gomes, Jonas Schünemann, Fabian Maass & Paul Lingor. (2018) Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease. Frontiers in Neuroscience 12.
Crossref
Eduard Tolosa, Teresa Botta-Orfila, Xavier Morató, Carles Calatayud, Raquel Ferrer-Lorente, María-José Martí, Manel Fernández, Carles Gaig, Ángel Raya, Antonella Consiglio, Mario Ezquerra & Rubén Fernández-Santiago. (2018) MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients. Neurobiology of Aging 69, pages 283-291.
Crossref
Eirini Kanata, Katrin Thüne, Konstantinos Xanthopoulos, Isidre Ferrer, Dimitra Dafou, Inga Zerr, Theodoros Sklaviadis & Franc Llorens. (2018) MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives. Frontiers in Aging Neuroscience 10.
Crossref
Ting-Yen Wei, Yun Fu, Kuo-Hsuan Chang, Kun-Ju Lin, Yu-Jen Lu & Chao-Min Cheng. (2018) Point-of-Care Devices Using Disease Biomarkers To Diagnose Neurodegenerative Disorders. Trends in Biotechnology 36:3, pages 290-303.
Crossref
Igor P Pogribny. (2017) MicroRNAs as biomarkers for clinical studies. Experimental Biology and Medicine 243:3, pages 283-290.
Crossref
Genevie Borrageiro, William Haylett, Soraya Seedat, Helena Kuivaniemi & Soraya Bardien. (2018) A review of genome-wide transcriptomics studies in Parkinson's disease. European Journal of Neuroscience 47:1, pages 1-16.
Crossref
Tuan Xu, Heidi Q. Xie, Yunping Li, Yingjie Xia, Rui Sha, Lingyun Wang, Yangsheng Chen, Li Xu & Bin Zhao. (2018) Dioxin induces expression of hsa-miR-146b-5p in human neuroblastoma cells. Journal of Environmental Sciences 63, pages 260-267.
Crossref
Williams Puszyk, Keith Robertson & Chen Liu. 2018. Precision Molecular Pathology of Liver Cancer. Precision Molecular Pathology of Liver Cancer 69 93 .
Loredana Leggio, Silvia Vivarelli, Francesca L’Episcopo, Cataldo Tirolo, Salvo Caniglia, Nunzio Testa, Bianca Marchetti & Nunzio Iraci. (2017) microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches. International Journal of Molecular Sciences 18:12, pages 2698.
Crossref
Jiangkun Lu, Yan Xu, Zhenzhen Quan, Zixuan Chen, Zhenzhen Sun & Hong Qing. (2017) Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson’s disease. Neuroscience 365, pages 70-82.
Crossref
Ahmad R. Arshad, Siti A. Sulaiman, Amalia A. Saperi, Rahman Jamal, Norlinah Mohamed Ibrahim & Nor Azian Abdul Murad. (2017) MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease. Frontiers in Molecular Neuroscience 10.
Crossref
Ying Wang, Zhaofei Yang & Weidong Le. (2017) Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson’s Disease. Neuroscience Bulletin 33:5, pages 543-551.
Crossref
Tuan Xu, Heidi Q. Xie, Yunping Li, Yingjie Xia, Yangsheng Chen, Li Xu, Lingyun Wang & Bin Zhao. (2017) CDC42 expression is altered by dioxin exposure and mediated by multilevel regulations via AhR in human neuroblastoma cells. Scientific Reports 7:1.
Crossref
Abhishek Singh & Dwaipayan Sen. (2017) MicroRNAs in Parkinson’s disease. Experimental Brain Research 235:8, pages 2359-2374.
Crossref
Xiong Zhang, Rui Yang, Bei-Lei Hu, Pengcheng Lu, Li-Li Zhou, Zhi-Yong He, Hong-Mei Wu & Jian-Hong Zhu. (2017) Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson’s Disease. Frontiers in Cellular Neuroscience 11.
Crossref
Mingshu Mo, Yousheng Xiao, Shuxuan Huang, Luan Cen, Xiang Chen, Limin Zhang, Qin Luo, Shaomin Li, Xinling Yang, Xian Lin & Pingyi Xu. (2016) MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian. Oncotarget 8:1, pages 15-28.
Crossref
Ilaria Grossi, Alessandro Salvi, Edoardo Abeni, Eleonora Marchina & Giuseppina De Petro. (2017) Biological Function of MicroRNA193a-3p in Health and Disease. International Journal of Genomics 2017, pages 1-13.
Crossref
S. Kumar, M. Vijayan, J.S. Bhatti & P.H. Reddy. 2017. Molecular Biology of Aging. Molecular Biology of Aging 47 94 .
Li Chen, Mingshu Mo, Guangning Li, Luan Cen, Lei Wei, Yousheng Xiao, Xiang Chen, Shaomin Li, Xinling Yang, Shaogang Qu & Pingyi Xu. (2016) The biomarkers of immune dysregulation and inflammation response in Parkinson disease. Translational Neurodegeneration 5:1.
Crossref
G Y He, J L Hu, L Zhou, X H Zhu, S N Xin, D Zhang, G F Lu, W T Liao, Y Q Ding & L Liang. (2016) The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer. British Journal of Cancer 115:11, pages 1367-1378.
Crossref
Wenbin Ma, Yingying Li, Chao Wang, Fan Xu, Meiling Wang & Yiming Liu. (2016) Serum miR-221 serves as a biomarker for Parkinson's disease. Cell Biochemistry and Function 34:7, pages 511-515.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.